Jasminder Kumar, PharmD, is a North America Regulatory Affairs Manager within the Global Regulatory Affairs Oncology group at Janssen Research & Development, LLC. At Janssen, she has contributed to the operational and strategic aspects of regional oncology drug development for early to late stage products. Prior to Janssen, Jasminder was a Risk Management Analyst at the FDA in the Division of Risk Management and worked collaboratively to determine the need for a risk evaluation mitigation strategy (REMS) throughout the drug development process. Jasminder also completed a Managed Care Residency at Horizon Blue Cross Blue Cross Blue Shield of NJ, focusing on formulary management. She received her Doctorate in Pharmacy from Rutgers University.